RE: New options, intriguing terms19 Jun 2024 10:52
Sort the options out before the music starts. Very reasonable awards at 11p - in line with shareholders interests
Plus, everything is on track and note the word "earlier" - nice.
"more agile executive team is allowing the business to focus on its three key objectives to achieve cash generation earlier, to grow and develop contract manufacture, to commercialise the heart valve leaflet material and to partner the remaining regulatory pathway for vascular grafts."